Logo wahanariau.com
  2. Boehringer ingelheim

Boehringer ingelheim

Index
Globenewswire

Survodutide Phase II Trial Shows 83% of Adults Treated Achieved Groundbreaking Results in Liver Disease Due to MASH, with Significant Improvements in Fibrosis

Selasa, 27 Februari 2024 - 04:51:28 Wib
Globenewswire

New Collaboration Between Boehringer Ingelheim and Sleip Leverages AI-technology to help Detect Lameness in Horses

Senin, 19 Februari 2024 - 16:30:00 Wib
Globenewswire

Boehringer Expands Production Site in Greece for New Medicine

Kamis, 11 Januari 2024 - 22:30:00 Wib